B.C.'s Applied Biologicals Commercializes R&D With Government Support
Applied Biological Materials Inc. of British Columbia has succeeded in commercializing a new detection system for genetic information.
Location Canada 2011
The company has developed a microRNA (miRNA) expression and detection system where miRNA is known to regulate the genome, which is the basic foundation for human health and medical conditions. The system is used in life science research and biotechnology industries across Canada and the world.
"Research in miRNA holds great promise for the life science community and can ultimately contribute to innovative diagnostic assays and therapeutic modalities. Through government of Canada support, Applied Biological Materials Inc. has been elevated to become one of the world's top players in this technology," said CEO Dr. Peter Li. "Our dominant position has opened and will continue to open new job opportunities in Canada. In short, it is almost impossible for Applied Biological Materials Inc. to take on cutting-edge research and development, like the miRNA project, without the government's support."
AstraZeneca Expands Mississauga, Ontario, Canada, Research-Development Campus
Magna Expands Ontario, Canada, Operations
Pfizer Expands Kalamazoo, Michigan, Operations
Siwin Foods Expands Edmonton, Alberta, Production Plant
The Cultivated B Plans Burlington, Ontario, Bioengineering Facility-Innovation Hub
Southland Trailer Plans Alberta, Canada, Manufacturing Plant
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
19th Annual Consultants Survey: Clients Challenged by Tight Labor Market, Energy Availability
The Top Investment Location Prospects for Aerospace Manufacturing
2022 Top States for Doing Business Provide an Environment for Business Growth
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
How Are Economic Developers Partnering to Solve Workforce Challenges?
Strategies to Overcome Intensifying Industrial Real Estate Challenges